Historique
Auteur K. MOELLER
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat à votre sélection Affiner la recherche
S. ANDERDAL BAKKEN ; K. MOELLER ; S. SANDBERG | 2018
Dans European Journal of Criminology (Vol.15, n°4, July 2018) Article : PériodiqueThe new drug markets emerging on the dark net have reduced earlier drug market risk factors such as visibility and violence. This study uses economic sociology and transaction cost economics to broaden the present understanding of cryptomarkets.[...]
K. MOELLER | 2012
Dans Drugs: Education, Prevention and Policy (Vol.19, n°5, October 2012) Article : PériodiqueAim: To establish estimates for the direct costs of policing cannabis in Copenhagen. Methods: Policing is disaggregated into the two tactical components of retail-level policing and crackdowns. Costs for retail-level policing are estimated usi[...]
A growing share of illicit drug dealing occurs on online platforms. Technological innovations, such as encryption and anonymous payments, have enabled new and more complex ways of organizing transactions. This conceptual essay advances the study[...]
K. MOELLER ; R. MUNKSGAARD ; J. DEMANT | 2021
Dans International Journal of Drug Policy (Vol.91, May 2021) Article : PériodiqueBackground: Illicit drugs are increasingly sold on cryptomarkets and on social media. Buyers and sellers perceive these online transactions as less risky than conventional street-level exchanges. Following the Risks & Prices framework, law enfor[...]
K. MOELLER ; B. SVENSSON | 2021
Dans Journal of Drug Issues (Vol.51, n°1, January 2021) Article : PériodiqueFentanyl analogs are synthetic opioids used for pain treatment and palliative care, which are also sought after by drug users for their psychoactive properties. Clandestinely produced fentanyl has caused an overdose crises of unprecedented scale[...]![The double effect of COVID-19 confinement measures and economic recession on high-risk drug users and drug services [Editorial]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_84259.webp)
C. COSTA STORTI ; A. L. BRETTEVILLE-JENSEN ; P. DE GRAUWE ; K. MOELLER ; J. MOUNTENEY ; A. STEVENS | 2021
Dans European Addiction Research (Vol.27, n°4, June 2021) Article : PériodiqueThe ongoing COVID-19 pandemic is likely to have a profound impact on the lives of high-risk drug users and on the services responding to their needs in at least two important ways: first, through the restrictive measures introduced to mitigate t[...]
C. COMISKEY ; H. BERGERON ; T. CLAUSEN ; C. COLMAN ; L. FERRER-WREDER ; G. FISCHER ; M. G. DE MATOS ; J. H. IVERS ; M. JAUFFRET-ROUSTIDE ; M. LIEM ; T. LINTONEN ; K. MOELLER ; I. OJANPERA ; F. R. DE FONSECA ; M. T. MELICH | 2024
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : PériodiqueIn July 2024 the long established and trusted European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will cease to exist and will evolve to the new European Drugs Agency (EUDA). In response to the ever diversifying, innovative and comp[...]
